Zscaler Stock Jumps As Wall Street Hikes AI Security Targets

Zscaler Inc. stocks have been trading up by 7.67 percent following upbeat analyst coverage highlighting robust cloud-security demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ZS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

Street is in full upgrade mode after Zscaler Inc.’s 2026 Investor Day, with Truist, Wells Fargo, Bank of America, Wedbush, Cantor, Canaccord, TD Cowen, Freedom Broker, Oppenheimer, RBC, and UBS all lifting price targets and backing bullish ratings.
Management is steering toward at least $8B in ARR by FY2031, with several firms modeling an upside path to $10B if AI security adoption and platform expansion track the high end.
Wedbush describes a base case of roughly 17% ARR CAGR to reach $8B by FY2031, with a faster AI-driven case pushing toward 22% CAGR, paired with a long-run 27%–30% operating margin profile.
Major brokers, including Bank of America, Truist, and TD Cowen, now lean on Zscaler Inc.’s AI security and Zero Trust platform story, seeing a bigger market beyond its original Zero Trust user access niche.
Shares popped more than 4% after Zscaler Inc. reaffirmed fiscal Q1 guidance and separately announced an Autonomous Application Shield integration with IBM and Red Hat’s Lightwell to secure private apps end to end.

Weekly Update Oct 19 – Oct 23, 2026: On Sunday, October 25, 2026 Zscaler Inc. stock [NASDAQ: ZS] is trending up by 7.67%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Technology industry expert:

Analyst sentiment – positive

Zscaler sits in the top tier of zero-trust security platforms, with strong scale and best-in-class gross margin at ~77%, but still GAAP-loss-making with EBIT margin around -0.4% and pretax margin -5.8%. Revenue of ~$3.35B is compounding at ~28% three-year and ~38% five-year CAGRs, with solid balance-sheet flexibility (net cash, current ratio 1.7, interest coverage >20x). High-price-to-sales (~11x) and rich price-to-cash-flow (~34x) embed continued mid‑20s%+ growth and sustained FCF leverage.

Technically, ZS is in a strong weekly uptrend, with successive closes from ~$213 to $256 and higher highs/lows each session, confirming aggressive institutional accumulation. The breakout through the $230–$235 congestion zone and strong close near the weekly high suggests buyers in control; intraday 5‑minute candles show shallow pullbacks being bought on above-average volume. A key actionable level is $236–$238: above it remains a long bias; a decisive break below would signal a failed breakout and short‑term mean reversion.

More Breaking News

The news flow and Street reaction are unequivocally constructive: multiple Tier‑1 brokers lifted targets into the $230–$275 range after Investor Day, anchored on a credible path to $8–$10B ARR by FY31 and mid‑high‑20s operating margins, outpacing typical Software & IT Services peers on growth but not yet on profitability. AI‑driven security and partnerships (IBM/Red Hat) strengthen ZS’s strategic moat. I see upside toward $270 over 12–18 months, with support ~$230 and resistance near $260–$270.

Quick Financial Overview

Zscaler Inc. is trading on strong momentum. The weekly chart shows a clear step-up from $212.80 to $256.00 over the recent five-day span, with closes pushing toward the top of each range. That kind of staircase action usually tells you big money is building positions rather than scalping for pennies. Intraday, a single wide-range 5-minute bar moving from an open around $238.81 to a close near $255.15, while undercutting $234.19 and tagging a $255.55 high, speaks to aggressive dip buying and shorts getting squeezed.

Under the hood, the story matches the tape. Zscaler Inc. posted about $3.35B in trailing revenue with revenue growth above 25% over three years and near 38% over five years, supported by a rich 76.8% gross margin. Profitability at the bottom line is still negative, with profit margins around -1.9% and return on equity near -10.8%, but EBITDA margin is positive at 8.7% and improving. Cash generation is solid: the latest quarter shows operating cash flow of roughly $279.3M and free cash flow of about $60.8M, even while the company spends heavily on capex and technology.

The balance sheet can support that growth push. Cash, cash equivalents, and short-term investments total about $3.47B against total debt near $1.80B, backed by a current ratio of 1.7 and a quick ratio of 1.6. Interest coverage above 20x and total debt-to-equity of 0.71 suggest leverage is controlled, not stretched. Valuation, however, is rich: price-to-sales is about 11.4 and price-to-free-cash near 160, with price-to-book around 14.7. That means the market is already pricing in years of high growth and better margins; for traders, the key is whether Zscaler Inc. can keep validating those expectations quarter after quarter.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!